Published in Eur J Immunol on March 01, 2006
Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest (2007) 5.05
Indoleamine 2,3-dioxygenase tissue distribution and cellular localization in mice: implications for its biological functions. J Histochem Cytochem (2009) 1.09
IL-17A-dependent CD4+CD25+ regulatory T cells promote immune privilege of corneal allografts. J Immunol (2011) 1.07
Immune escape mechanisms of intraocular tumors. Prog Retin Eye Res (2009) 1.07
Immune privilege of corneal allografts. Ocul Immunol Inflamm (2010) 1.01
The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects. J Cell Mol Med (2009) 1.01
IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival. J Immunol (2011) 1.00
Strategies for local gene therapy of corneal allograft rejection. Middle East Afr J Ophthalmol (2013) 0.94
3-hydroxykynurenine suppresses CD4+ T-cell proliferation, induces T-regulatory-cell development, and prolongs corneal allograft survival. Invest Ophthalmol Vis Sci (2011) 0.93
Arginine depletion as a mechanism for the immune privilege of corneal allografts. Eur J Immunol (2011) 0.93
Gene therapy in the cornea: 2005--present. Prog Retin Eye Res (2011) 0.92
Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism? Front Immunol (2012) 0.90
Tregs and infections: on the potential value of modifying their function. J Leukoc Biol (2011) 0.88
Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition. Eur J Immunol (2013) 0.88
Corneal gene therapy: basic science and translational perspective. Ocul Surf (2013) 0.87
Function of the tryptophan metabolite, L-kynurenine, in human corneal endothelial cells. Mol Vis (2009) 0.87
Paradigm shifts in the role of CD4+ T cells in keratoplasty. Discov Med (2010) 0.87
Altered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases. Front Immunol (2012) 0.85
Comparison of non-viral methods to genetically modify and enrich populations of primary human corneal endothelial cells. Mol Vis (2009) 0.83
Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion. Exp Eye Res (2007) 0.83
Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization. Nucleic Acids Res (2009) 0.80
Indoleamine 2,3-dioxygenase depletes tryptophan, activates general control non-derepressible 2 kinase and down-regulates key enzymes involved in fatty acid synthesis in primary human CD4+ T cells. Immunology (2015) 0.79
Cytomegalovirus impairs the induction of indoleamine 2,3-dioxygenase mediated antimicrobial and immunoregulatory effects in human fibroblasts. PLoS One (2013) 0.78
Suppression of the allogeneic response by the anti-allergy drug N-(3,4-dimethoxycinnamonyl) anthranilic acid results from T-cell cycle arrest. Immunology (2013) 0.77
Role of NKT cells in anterior chamber-associated immune deviation. Expert Rev Clin Immunol (2009) 0.77
The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy. Int J Tryptophan Res (2016) 0.76
High-risk corneal allografts: A therapeutic challenge. World J Transplant (2016) 0.75
Gene therapy in corneal transplantation. Semin Ophthalmol (2013) 0.75
Immuno-regulatory function of indoleamine 2,3 dioxygenase through modulation of innate immune responses. PLoS One (2013) 0.75
Expression of indoleamine 2,3-dioxygenase in a murine model of Aspergillus fumigatus keratitis. Int J Ophthalmol (2016) 0.75
Effects of Foxp3 gene modified dendritic cells on mouse corneal allograft rejection. Int J Clin Exp Med (2015) 0.75
Effects of Cigarette Smoking on Transplant Survival: Extending or Shortening It? Front Immunol (2017) 0.75
The presence of kynurenine aminotransferases in the human cornea: Evidence from bioinformatics analysis of gene expression and immunohistochemical staining. Mol Vis (2017) 0.75
Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One (2010) 4.66
Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology (2005) 4.10
Mouse DNA contamination in human tissue tested for XMRV. Retrovirology (2010) 2.65
In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. Blood (2006) 2.28
Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. J Virol (2008) 2.27
The safety and side effects of monoclonal antibodies. Nat Rev Drug Discov (2010) 2.23
Diagnostic accuracy of microbial keratitis with in vivo scanning laser confocal microscopy. Br J Ophthalmol (2010) 1.96
Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J Virol (2005) 1.84
Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut (2010) 1.77
Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol (2003) 1.73
DNA extraction columns contaminated with murine sequences. PLoS One (2011) 1.55
Ubiquitin-dependent virus particle budding without viral protein ubiquitination. Proc Natl Acad Sci U S A (2007) 1.51
Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis (2002) 1.42
Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor. J Biol Chem (2005) 1.40
A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis. Br J Ophthalmol (2011) 1.39
Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy. AIDS (2002) 1.33
Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS (2009) 1.28
B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection. Nat Commun (2010) 1.26
Quality of vision and graft thickness in deep anterior lamellar and penetrating corneal allografts. Am J Ophthalmol (2006) 1.26
Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. Blood (2005) 1.24
A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. J Virol Methods (2008) 1.21
In vivo biological activity of the histone deacetylase inhibitor LAQ824 is detectable with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography. Cancer Res (2006) 1.19
Detection of vascular expression of E-selectin in vivo with MR imaging. Radiology (2006) 1.18
High prevalence of macrolide resistant Treponema pallidum strains in a London centre. Sex Transm Infect (2011) 1.18
Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J Immunol (2005) 1.15
Inflammatory cytokines induce apoptosis of corneal endothelium through nitric oxide. Invest Ophthalmol Vis Sci (2004) 1.13
Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemia. J Virol Methods (2004) 1.09
Identification of domains in gag important for prototypic foamy virus egress. J Virol (2005) 1.09
Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection. Clin Vaccine Immunol (2009) 1.05
Gene delivery by dendrimers operates via a cholesterol dependent pathway. Nucleic Acids Res (2004) 1.03
Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer. Cancer Immunol Immunother (2013) 1.01
Identification of synovium-specific homing peptides by in vivo phage display selection. Arthritis Rheum (2002) 1.01
Investigation into the presence of and serological response to XMRV in CFS patients. PLoS One (2011) 1.01
Restriction of V3 region sequence divergence in the HIV-1 envelope gene during antiretroviral treatment in a cohort of recent seroconverters. Retrovirology (2013) 1.00
Oscillations in the immune system. Immunol Rev (2007) 1.00
Reconstruction of cell population dynamics using CFSE. BMC Bioinformatics (2007) 0.99
Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection. Invest Ophthalmol Vis Sci (2003) 0.99
T-lymphocyte invasiveness: control by voltage-gated Na+ channel activity. FEBS Lett (2004) 0.98
Feedback control of T-cell receptor activation. Proc Biol Sci (2004) 0.98
Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors. J Gene Med (2005) 0.98
Nasotemporal asymmetry of retinopathy of prematurity. Arch Ophthalmol (2003) 0.98
Cell-cycle dependence of foamy virus vectors. J Gen Virol (2004) 0.98
Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41. PLoS Pathog (2011) 0.98
Effect of time since exposure to Chlamydia trachomatis on chlamydia antibody detection in women: a cross-sectional study. Sex Transm Infect (2013) 0.97
Cell therapy to promote transplantation tolerance: a winning strategy? Immunotherapy (2011) 0.96
3-hydroxykynurenine suppresses CD4+ T-cell proliferation, induces T-regulatory-cell development, and prolongs corneal allograft survival. Invest Ophthalmol Vis Sci (2011) 0.93
Generation and expansion of human CD4+ CD25+ regulatory T cells with indirect allospecificity: Potential reagents to promote donor-specific transplantation tolerance. Transplantation (2006) 0.93
Arginine depletion as a mechanism for the immune privilege of corneal allografts. Eur J Immunol (2011) 0.93
Gene delivery by dendrimers operates via different pathways in different cells, but is enhanced by the presence of caveolin. J Immunol Methods (2006) 0.93
Comparison of fecal biota from specific pathogen free and feral mice. Anaerobe (2006) 0.92
A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites. Eur J Immunol (2004) 0.92
Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival. Invest Ophthalmol Vis Sci (2002) 0.92
The effects of a nucleoside-sparing antiretroviral regimen on the pharmacokinetics of ritonavir-boosted darunavir in HIV type-1-infected patients. Antivir Ther (2010) 0.92
Chlamydia trachomatis infection increases fallopian tube PROKR2 via TLR2 and NFκB activation resulting in a microenvironment predisposed to ectopic pregnancy. Am J Pathol (2010) 0.91
Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction. Exp Eye Res (2005) 0.90
Effect of vectors on human endothelial cell signal transduction: implications for cardiovascular gene therapy. Arterioscler Thromb Vasc Biol (2005) 0.90
Synthesis and in vitro evaluation of [18F]fluoroethyl triazole labelled [Tyr3]octreotate analogues using click chemistry. Bioorg Med Chem Lett (2011) 0.90
Induction of replication in human corneal endothelial cells by E2F2 transcription factor cDNA transfer. Invest Ophthalmol Vis Sci (2005) 0.89
Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression. Blood (2005) 0.89
Xenotropic murine leukaemia virus-related virus (XMRV) does not cause chronic fatigue. Trends Microbiol (2011) 0.89
Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors. Cancer Immunol Immunother (2007) 0.88
Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition. Eur J Immunol (2013) 0.88
Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury. Am J Physiol Renal Physiol (2014) 0.87
Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role? Transplant Rev (Orlando) (2010) 0.87
Regulation of rat and human T-cell immune response by pharmacologically modified dendritic cells. Transplantation (2009) 0.86
Effect of glaucoma on corneal graft survival according to indication for penetrating keratoplasty. Am J Ophthalmol (2010) 0.86
Delivery of oligodeoxynucleotides into human saphenous veins and the adjunct effect of ultrasound and microbubbles. Ultrasound Med Biol (2005) 0.86
Immune modulation in corneal transplantation. Transplant Rev (Orlando) (2008) 0.85
C. trachomatis Pgp3 antibody prevalence in young women in England, 1993-2010. PLoS One (2013) 0.84
Targeting somatostatin receptors: preclinical evaluation of novel 18F-fluoroethyltriazole-Tyr3-octreotate analogs for PET. J Nucl Med (2011) 0.84
Getting the measure of syphilis: qPCR to better understand early infection. Sex Transm Infect (2011) 0.84
Gene therapy for transplantation with viral vectors--how much of the promise has been realised? Expert Opin Biol Ther (2006) 0.84
Targeting gene delivery to activated vascular endothelium using anti E/P-Selectin antibody linked to PAMAM dendrimers. J Immunol Methods (2009) 0.83
A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer. Cancer Immunol Immunother (2004) 0.83
Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk. Am J Ophthalmol (2010) 0.83
Xenon treatment attenuates early renal allograft injury associated with prolonged hypothermic storage in rats. FASEB J (2013) 0.82
No Evidence of XMRV or MuLV Sequences in Prostate Cancer, Diffuse Large B-Cell Lymphoma, or the UK Blood Donor Population. Adv Virol (2011) 0.82
Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis. Arthritis Rheum (2011) 0.82
Immunolipoplexes: an efficient, nonviral alternative for transfection of human dendritic cells with potential for clinical vaccination. Mol Ther (2005) 0.82
Hydrophobic modification of low molecular weight polyethylenimine for improved gene transfection. Biomaterials (2013) 0.82
In vitro demonstration of apoptosis mediated photodynamic activity and NIR nucleus imaging through a novel porphyrin. ACS Chem Biol (2012) 0.81
Expression of the chemokine antagonist vMIP II using a non-viral vector can prolong corneal allograft survival. Transplantation (2008) 0.81
Vascular endothelial growth factor receptors and the therapeutic targeting of angiogenesis in cancer: where do we go from here? Cell Commun Adhes (2011) 0.81
Tolerant T cells display impaired trafficking ability. Eur J Immunol (2005) 0.81
Differential effects of costimulatory pathway modulation on corneal allograft survival. Invest Ophthalmol Vis Sci (2006) 0.81